Status | Study |
Recruiting |
Study Name: Safety and Durability of Sirolimus for Treatment of LAM Condition: Lymphangioleiomyomatosis Date: 2015-03-04 Interventions: Drug: Sirolimus Sirolimus trea |
Completed |
Study Name: Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Condition: PEComa Hemangioma Date: 2014-12-22 Interventions: Other: Biopsy |
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition: Adult Fibrosarcoma Alveolar Soft Part Sarcoma Angiomatoid Date: 2014-07-01 Interventions: Drug: Doxorubicin Hydrochloride |
Completed |
Study Name: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) Condition: Pulmonary Lymphangioleiomyomatosis Date: 2014-04-15 Interventions: Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont |
Completed |
Study Name: Pulmonary Rehabilitation in Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2013-12-04 Interventions: Other: Pulmonary Rehabilitation |
Recruiting |
Study Name: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2013-02-23 Interventions: Drug: albuterol inhaler Procedure: PFT |
Withdrawn |
Study Name: A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Condition: Malignant PEComa (Perivascular Epithelioid Cell Tumors) Date: 2012-09-06 Interventions: Drug: BEZ235 Patients will be provided with an adequate supply of study treatment for self-administratio |
Completed |
Study Name: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2012-08-02 Interventions: Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o |
Recruiting |
Study Name: National Lymphangioleiomyomatosis Registry, France Condition: Lymphangioleiomyomatosis Date: 2011-11-30 |
Completed |
Study Name: Trial of Aromatase Inhibition in Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2011-05-11 Interventions: Drug: Letrozole 2.5 mg daily f |